Requested Daily News Article

SENS 2 Report, John Furber (Tuesday September 27 2005) Another of Frank Rummel's reports from the recent Strategies for Engineered Negligible Senescence conference (SENS 2) is up, with a focus on John Furber of Legendary Pharmaceuticals. As his SENS 2 presentation makes clear, Furber is involved in the search for AGE-breakers - drugs or therapies capable of breaking down the detrimental accumulation of advanced glycation end products (AGEs) and crosslinked proteins with age. "Extracellular aging - accumulating molecular damage by glycation, oxidation, and crosslinking of long-lived extracellular proteins, mainly collagen and elastin - is a major cause of several important human aging pathologies." This is an interesting area of study, and perhaps the field of SENS most likely to benefit from traditional approaches to drug discovery and medical research. Link to original article   Share |

Prior News Socialized Medicine, Broken By Design Tissue Engineering A Diabetes Cure Parkinson's Gene Therapy: Modest Progress Boosting The Elderly Immune System People Who Want To Age And Die

Later News Cryopreserved Stem Cells Work Fine On Placental Stem Cells Wired On Regenerating Mice The Tithonus Error Is Alive And Well New Calorie Restriction Gene In Yeast

We help you stay up to date with the most interesting news in medicine, politics and the healthy life extension community. You can help us by contacting us when you see interesting items online. You can search past news postings through Google by using the form to the right.

Search Past News     Search